JPWO2022255499A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022255499A5 JPWO2022255499A5 JP2023525939A JP2023525939A JPWO2022255499A5 JP WO2022255499 A5 JPWO2022255499 A5 JP WO2022255499A5 JP 2023525939 A JP2023525939 A JP 2023525939A JP 2023525939 A JP2023525939 A JP 2023525939A JP WO2022255499 A5 JPWO2022255499 A5 JP WO2022255499A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- carboxamide
- thiophene
- formula
- pharma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021094481 | 2021-06-04 | ||
| PCT/JP2022/023390 WO2022255499A1 (ja) | 2021-06-04 | 2022-06-03 | 新規なamp活性化プロテインキナーゼ活性化剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022255499A1 JPWO2022255499A1 (cg-RX-API-DMAC7.html) | 2022-12-08 |
| JPWO2022255499A5 true JPWO2022255499A5 (cg-RX-API-DMAC7.html) | 2025-06-09 |
Family
ID=84322602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525939A Pending JPWO2022255499A1 (cg-RX-API-DMAC7.html) | 2021-06-04 | 2022-06-03 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12622891B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4349331A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2022255499A1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN117794527A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022255499A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004043366A2 (en) | 2002-11-06 | 2004-05-27 | Smithkline Beecham Corporation | Sulfonamides |
| TW200424174A (en) | 2003-02-06 | 2004-11-16 | Hoffmann La Roche | New TP diamide |
| US20050090529A1 (en) | 2003-07-31 | 2005-04-28 | Pfizer Inc | 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| ES2328820T3 (es) | 2003-10-17 | 2009-11-18 | Astrazeneca Ab | Derivados de 4-(pirazol-3-ilamino)pirimidina para uso en el tratamiento de cancer. |
| DE102004039876A1 (de) | 2004-06-23 | 2006-01-26 | Lanxess Deutschland Gmbh | Herstellung von fluorierten 1,3-Benzodioxanen |
| JP2008007405A (ja) | 2004-12-07 | 2008-01-17 | Takeda Chem Ind Ltd | カルボキサミド誘導体 |
| CA2598458A1 (en) | 2005-02-16 | 2006-08-24 | Schering Corporation | Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| JP2011178728A (ja) | 2010-03-02 | 2011-09-15 | Kobe Univ | Ampk活性化剤、glut4活性化剤、およびそれらを用いた医薬品・飲食品 |
| JP2013212994A (ja) * | 2010-06-22 | 2013-10-17 | Sanwa Kagaku Kenkyusho Co Ltd | 新規チオフェンカルボキサミド誘導体及びその医薬用途 |
| US20130345243A1 (en) | 2011-03-07 | 2013-12-26 | Glaxosmithkline Llc | 1h-pyrollo[3,2-d]pyrimidinedione derivatives |
| WO2014069426A1 (ja) * | 2012-10-31 | 2014-05-08 | 塩野義製薬株式会社 | Ampk活性化作用を有するベンズイミダゾールおよびアザベンズイミダゾール誘導体 |
| CA2950119C (en) | 2013-06-18 | 2021-09-14 | Albert Einstein College Of Medicine, Inc. | Treatment of obesity and pulmonary arterial hypertension |
| SG11201908817WA (en) | 2017-03-21 | 2019-10-30 | Fujifilm Corp | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound |
| JP7131034B2 (ja) | 2018-03-30 | 2022-09-06 | 株式会社三洋物産 | 遊技機 |
| JP7185226B2 (ja) * | 2018-11-22 | 2022-12-07 | 国立大学法人 鹿児島大学 | 1,5-アンヒドロフルクトース誘導体を含むampk活性化剤 |
| US11299582B2 (en) * | 2019-04-29 | 2022-04-12 | The Government Of The United States Of America, As Represented By The Secretary Of The Navy | Breathable elastomeric composites with tether-containing conducting polymers for nanoscale diffusion control and protection |
-
2022
- 2022-06-03 JP JP2023525939A patent/JPWO2022255499A1/ja active Pending
- 2022-06-03 EP EP22816244.2A patent/EP4349331A4/en active Pending
- 2022-06-03 CN CN202280053568.2A patent/CN117794527A/zh active Pending
- 2022-06-03 WO PCT/JP2022/023390 patent/WO2022255499A1/ja not_active Ceased
- 2022-06-03 US US18/566,730 patent/US12622891B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016011316A (ja) | カリケアマイシン誘導体のコンバージェント合成方法 | |
| Lee et al. | Synthesis of 5-(7-hydroxyhept-3-enyl)-1, 2-dithiolan-3-one 1-oxide, a core functionality of antibiotic leinamycin | |
| CN104892555A (zh) | 曲前列尼尔中间体的制备方法 | |
| CN102126993A (zh) | 白藜芦醇衍生物及其在制备抗癌药物中的应用 | |
| JP6407645B2 (ja) | 芳香族化合物のパーフルオロアルキル化反応 | |
| Bosiak et al. | Synthesis and photoluminescence properties of star-shaped 2, 3, 6, 7-tetrasubstituted benzo [1, 2-b: 4, 5-b′] difurans | |
| CN106146418B (zh) | 一种nh-1,2,3-三唑化合物的合成方法 | |
| JP5298636B2 (ja) | ペンタフルオロスルファニル基を有する複素環オリゴマー化合物 | |
| JP2019089847A (ja) | カリケアマイシン誘導体を合成するための中間体および方法 | |
| JP7672653B2 (ja) | 化合物及びその製造方法 | |
| JP2015129098A (ja) | 2,7置換[1]ベンゾチエノ[3,2−b][1]ベンゾチオフェン誘導体の製造方法 | |
| JP2017031097A (ja) | ジチエノベンゾジフラン誘導体の製造方法 | |
| JP5305321B2 (ja) | フルオロ化合物の製造方法 | |
| CN107603271B (zh) | 一种长链烷氧基bodipy化合物的制备方法 | |
| CN101130529A (zh) | 光学活性2,3-二羟基丁内半缩醛衍生物的制备方法 | |
| JP7301337B2 (ja) | 化合物及びその製造方法 | |
| CN111100063B (zh) | 一种合成2-氟甲基取代的吡咯烷、哌啶以及哌嗪衍生物的制备方法 | |
| CN121609690A (zh) | 一种苯并噻吩-3-酮和3-氧取代苯并噻吩的一锅法合成方法 | |
| JP4780372B2 (ja) | キノキサリンジオン誘導体及びその製造方法並びにその用途 | |
| JP5765371B2 (ja) | ペンタフルオロスルファニル基を有する複素環オリゴマー化合物 | |
| KR101823271B1 (ko) | 신규한 비대칭 상 이동 촉매 및 이를 이용한 알파-아미노산의 제조방법 | |
| US20050033090A1 (en) | Process for the preparation of cinnamaldehyde compounds | |
| JP4475901B2 (ja) | 3−アセチルチオフェン類の製造方法 | |
| JP2024150858A (ja) | 含フッ素ジアミン化合物の製造方法 | |
| CN103242176A (zh) | 基于氯化胆碱的功能离子液体及其制备方法 |